top of page
Report Summary
Market Overview

Global C-reactive Protein Testing Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global C-reactive Protein Testing Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Assay Type (Enzyme-linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay, and Other Assay Types), Application (Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, and Other Applications), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Market Overview


The Global C-reactive Protein Testing Market was valued at USD 5,671.8 million in 2023 and is expected to reach USD 6,541.9 million by 2031 while growing at a CAGR of 1.8% during the forecast period (2024-2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global C-reactive protein testing market growth. C-reactive protein (CRP) testing, a blood test measuring CRP levels produced by the liver in response to inflammation, is employed to assess the presence and severity of inflammation in the body.


The increasing prevalence of inflammatory diseases and the rise in cardiovascular diseases are expected to drive the growth of the C-reactive protein testing market. Nevertheless, obstacles like cost constraints and stringent regulatory requirements for new CRP testing products may hinder market expansion.


Furthermore, the global C-reactive protein testing industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Assay Type Analysis


The Global C-reactive Protein Testing Market is segmented among Enzyme-linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay, and Other Assay Types, based on Assay Type. In 2023, Immunoturbidimetric Assay accounted for the majority of the market share*. 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By Application Analysis


The Global C-reactive Protein Testing Market is segmented among Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, and Other Applications, based on Application. In 2023, Cardiovascular Disease accounted for the majority of the market share*.

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global C-reactive Protein Testing Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031). 

 *Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Zoetis (Abaxis Inc.), Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), F. Hoffmann-La Roche AG, Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics, Randox Laboratories Ltd, Siemens Healthineers, and Thermo Fisher Scientific Inc.


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global C-reactive Protein Testing Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global C-reactive Protein Testing Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global C-reactive Protein Testing Market Segmentation, By Assay Type

  • Global C-reactive Protein Testing Market Share Analysis, By Assay Type

  • Global C-reactive Protein Testing Market Growth Analysis, By Assay Type

  • Global C-reactive Protein Testing Market Trends, By Assay Type

o Enzyme-linked Immunosorbent Assay (ELISA)

o Chemiluminescence Immunoassay (CLIA)

o Immunoturbidimetric Assay

o Other Assay Types

6. Global C-reactive Protein Testing Market Segmentation, By Application

  • Global C-reactive Protein Testing Market Share Analysis, By Application

  • Global C-reactive Protein Testing Market Growth Analysis, By Application

  • Global C-reactive Protein Testing Market Trends, By Application

o Diabetes

o Rheumatoid Arthritis

o Cardiovascular Disease

o Inflammatory Bowel Disease

o Cancer

o Other Applications

7. Global C-reactive Protein Testing Market Segmentation, By Region

  • Global C-reactive Protein Testing Market Share Analysis, By Region

  • Global C-reactive Protein Testing Market Growth Analysis, By Region

  • Global C-reactive Protein Testing Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

  • Zoetis (Abaxis Inc)*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Abbott Laboratories

  • Danaher Corporation (Beckman Coulter Inc.)

  • F. Hoffmann-La Roche AG

  • Laboratory Corporation of America Holdings

  • Merck KGaA

  • Quest Diagnostics

  • Randox Laboratories Ltd

  • Siemens Healthineers

  • Thermo Fisher Scientific Inc.

 *Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page